You are here

Pharmaceutical Approval Update October 2007

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Topics include the rivastigmine transdermal system (Exelon Patch) for mild-to-moderate dementia of the Alzheimer’s type and for mild-to-moderate dementia associated with Parkinson’s disease; armodafinil (Nuvigil) for improving wakefulness; and ambrisentan (Letairis) for pulmonary arterial hypertension.